Schonfeld Strategic Advisors LLC Verrica Pharmaceuticals Inc. Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.17 - $4.3 $41,664 - $82,560	-19,200 Reduced 58.9%	13,400 $39,000
Q2 2022 Aug 15, 2022	BUY	$1.81 - $8.93 $59,006 - $291,118	32,600 New	32,600 $62,000
Q2 2021 Aug 16, 2021	SELL	$9.77 - $15.33 $432,938 - $679,318	-44,313 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.51 - $17.46 $465,729 - $773,704	44,313 New	44,313 $672,000
Q4 2019 Feb 14, 2020	SELL	$13.08 - $17.43 $1.68 Million - $2.24 Million	-128,469 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$8.65 - $14.81 $1.11 Million - $1.9 Million	128,469 New	128,469 $1.9 Million

17.4M

6.1K

6.3K

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.